Annovis Bio, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | — | — | $35.3K |
| FY2019 | $2.6M | $1.1M | $1.9K |
| FY2020 | $578.4K | $8.1M | $8.1M |
| FY2021 | $1.5M | $46.0M | $45.7M |
| FY2022 | $1.4M | $44.1M | $42.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | — | — | $35.3K |
| FY2019 | $2.6M | $1.1M | $1.9K |
| FY2020 | $578.4K | $8.1M | $8.1M |
| FY2021 | $1.5M | $46.0M | $45.7M |
| FY2022 | $1.4M | $44.1M | $42.7M |